| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: chemotherapy regimen consisting of fluorouracil, folinic acid & oxaliplatin for treatment of metastatic gastric cancer
| 1. | Hentrich, M: 1 article (07/2005) |
| 2. | Zumschlinge, R: 1 article (07/2005) |
| 3. | Bredenkamp, R: 1 article (07/2005) |
| 4. | Lordick, F: 1 article (07/2005) |
| 5. | Duyster, J: 1 article (07/2005) |
| 6. | Hennig, M: 1 article (07/2005) |
| 7. | Dietzfelbinger, H: 1 article (07/2005) |
| 8. | Vehling-Kaiser, U: 1 article (07/2005) |
| 9. | Seroneit, T: 1 article (07/2005) |
| 10. | Kullmann, F: 1 article (07/2005) |
| 1. | Stomach Neoplasms (Stomach Cancer)
07/25/2005
- "The weekly FUFOX regimen is well tolerated and shows notable activity as first-line treatment in metastatic gastric cancer."
07/25/2005 - "Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer." Order ALL the reference details at left... |
| 2. | Colorectal Neoplasms (Colorectal Cancer)
05/01/2008
- "BACKGROUND: The aim of the study was to establish the recommended dose and to evaluate the safety of gefitinib plus FUFOX regimen in irinotecan-refractory colorectal carcinoma (CRC). "
Order ALL the reference details at left... |
| 1. | Fluorouracil (Carac)
|
| 2. | Leucovorin (Folinic Acid)
|
| 3. | oxaliplatin (Eloxatin)
|
| 4. | gefitinib (Iressa)
|
| 5. | irinotecan (Camptosar)
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |